University Briefs

I’d Like You To Know Me Better H. T. Kung, professor of computer science at Carnegie-Mellon, had a good thing going. Instead of asking industry for money to fund his research, he would brashly invite companies to bid for the privilege. In the past, this tactic snared top dollars from General Electric, Honeywell, and Intel. But when Kung recently invited 12 major high-tech firms to join him on his latest project, a computer network, he only received sub-par offers. “We were too opti

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

H. T. Kung, professor of computer science at Carnegie-Mellon, had a good thing going. Instead of asking industry for money to fund his research, he would brashly invite companies to bid for the privilege. In the past, this tactic snared top dollars from General Electric, Honeywell, and Intel. But when Kung recently invited 12 major high-tech firms to join him on his latest project, a computer network, he only received sub-par offers. “We were too optimistic,” Kung says. So now he’s adding a new wrinkle; he’s invited the companies to sit on a committee he’s formed to better inform the firms about his research. And he hopes that they will come back with better offers when he puts the project up for bid again this fall.

Fossils are the remains of animals that died in the flood that Noah sat out, cavemen fought off marauding dinosaurs, and human life originated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies